, Available at: www.lgcstandards -atcc, ATCC Virus Reference MaterialsATCC_Virus_Reference_ Materials, 2014.

E. Ayuso, F. Mingozzi, and J. Montane, High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency, Gene Therapy, vol.17, issue.4, pp.503-510, 2010.
DOI : 10.1182/blood-2007-03-080093

E. Ayuso, V. Blouin, and C. Darmon, Reference materials for the characterization of adeno-associated viral vectors, The Clinibook: Clinical Gene Transfer State of the Art. O. Cohen-haguenauer, pp.83-90, 2012.

J. W. Bainbridge, A. J. Smith, and S. S. Barker, Effect of Gene Therapy on Visual Function in Leber's Congenital Amaurosis, New England Journal of Medicine, vol.358, issue.21, pp.2231-2239, 2008.
DOI : 10.1056/NEJMoa0802268

L. M. Bryant, D. M. Christopher, and A. R. Giles, Lessons Learned from the Clinical Development and Market Authorization of Glybera, Human Gene Therapy Clinical Development, vol.24, issue.2, pp.55-64, 2013.
DOI : 10.1089/humc.2013.087

C. Burger, O. S. Gorbatyuk, and M. J. Velardo, Recombinant AAV Viral Vectors Pseudotyped with Viral Capsids from Serotypes 1, 2, and 5 Display Differential Efficiency and Cell Tropism after Delivery to Different Regions of the Central Nervous System, Molecular Therapy, vol.10, issue.2, pp.302-317, 2004.
DOI : 10.1016/j.ymthe.2004.05.024

G. P. Gao, M. R. Alvira, and L. Wang, Novel adenoassociated viruses from rhesus monkeys as vectors for human gene therapy, Proc. Natl. Acad. Sci. USA 99, pp.11854-11859, 2002.

G. Gao, L. H. Vandenberghe, and M. R. Alvira, Clades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues, Journal of Virology, vol.78, issue.12, pp.6381-6388, 2004.
DOI : 10.1128/JVI.78.12.6381-6388.2004

D. Gaudet, J. Methot, and S. Dery, Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial, Gene Therapy, vol.11, issue.4, pp.361-369, 2013.
DOI : 10.1111/j.1365-2249.1990.tb05341.x

D. Grimm, A. Kern, and M. Pawlita, Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2, Gene Therapy, vol.71, issue.7, pp.1322-1330, 1999.
DOI : 10.1016/0042-6822(80)90071-9

B. Hutchins, Development of a Reference Material for Characterizing Adenovirus Vectors, BioProcessing Journal, vol.1, issue.1, pp.25-29, 2002.
DOI : 10.12665/J11.Hutchins

D. Kuck, A. Kern, and J. A. Kleinschmidt, Development of AAV serotype-specific ELISAs using novel monoclonal antibodies, Journal of Virological Methods, vol.140, issue.1-2, pp.17-24, 2007.
DOI : 10.1016/j.jviromet.2006.10.005

R. C. Littell, G. A. Milliken, and W. W. Stroup, SAS for Mixed Models, 2006.

M. Lock, S. Mcgorray, and A. Auricchio, Characterization of a Recombinant Adeno-Associated Virus Type 2 Reference Standard Material, Human Gene Therapy, vol.21, issue.10, pp.1273-1285, 2010.
DOI : 10.1089/hum.2009.223

M. Lock, M. R. Alvira, and S. J. Chen, Absolute Determination of Single-Stranded and Self-Complementary Adeno-Associated Viral Vector Genome Titers by Droplet Digital PCR, Human Gene Therapy Methods, vol.25, issue.2, pp.115-125, 2014.
DOI : 10.1089/hgtb.2013.131

A. M. Maguire, F. Simonelli, and E. A. Pierce, Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis, New England Journal of Medicine, vol.358, issue.21, pp.2240-2248, 2008.
DOI : 10.1056/NEJMoa0802315

C. S. Manno, V. R. Arruda, and G. F. Pierce, Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response, Nature Medicine, vol.24, issue.3, pp.342-347, 2006.
DOI : 10.1002/hep.1840200104

F. Mingozzi, M. V. Maus, and D. J. Hui, CD8+ T-cell responses to adeno-associated virus capsid in humans, Nature Medicine, vol.12, issue.4, pp.419-422, 2007.
DOI : 10.1038/nm1549

F. Mingozzi, J. J. Meulenberg, and D. J. Hui, AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells, Blood, vol.114, issue.10, pp.2077-2086, 2009.
DOI : 10.1182/blood-2008-07-167510

F. Mingozzi, X. M. Anguela, and G. Pavani, Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys, Science Translational Medicine, vol.109, issue.4, 2013.
DOI : 10.1182/blood-2006-03-010181

I. Mohiuddin, S. Loiler, and I. Zolotukhin, Herpesvirus-based infectious titering of recombinant adeno-associated viral vectors, Molecular Therapy, vol.11, issue.2, pp.320-326, 2005.
DOI : 10.1016/j.ymthe.2004.08.030

P. Moullier and R. O. Snyder, International Efforts for Recombinant Adeno-associated Viral Vector Reference Standards, Molecular Therapy, vol.16, issue.7, pp.1185-1188, 2008.
DOI : 10.1038/mt.2008.125

P. Moullier and R. O. Snyder, Recombinant Adeno-Associated Viral Vector Reference Standards, Methods Enzymol, vol.507, pp.297-311, 2012.
DOI : 10.1016/B978-0-12-386509-0.00015-6

A. C. Nathwani, E. G. Tuddenham, and S. Rangarajan, Adenovirus-Associated Virus Vector???Mediated Gene Transfer in Hemophilia B, New England Journal of Medicine, vol.365, issue.25, pp.2357-2365, 2011.
DOI : 10.1056/NEJMoa1108046

M. Potter, G. Phillipsber, and T. Phillipsberg, Manufacture and stability study of the recombinant adeno-associated virus serotype 2 reference standard, Bioprocessing J, vol.7, pp.8-14, 2008.

T. Rabilloud, J. M. Strub, and S. Luche, A comparison between Sypro Ruby and ruthenium II tris (bathophenanthroline disulfonate) as fluorescent stains for protein detection in gels, PROTEOMICS, vol.1, issue.5, pp.699-704, 2001.
DOI : 10.1002/1615-9861(200104)1:5<699::AID-PROT699>3.0.CO;2-C

R. O. Snyder and T. R. Flotte, Production of clinical-grade recombinant adeno-associated virus vectors, Current Opinion in Biotechnology, vol.13, issue.5, pp.418-423, 2002.
DOI : 10.1016/S0958-1669(02)00369-5

J. M. Sommer, P. H. Smith, and S. Parthasarathy, Quantification of adeno-associated virus particles and empty capsids by optical density measurement, Molecular Therapy, vol.7, issue.1, pp.122-128, 2003.
DOI : 10.1016/S1525-0016(02)00019-9

F. Sonntag, K. Kother, and K. Schmidt, The Assembly-Activating Protein Promotes Capsid Assembly of Different Adeno-Associated Virus Serotypes, Journal of Virology, vol.85, issue.23, pp.12686-12697, 2011.
DOI : 10.1128/JVI.05359-11

J. Tessier, G. Chadeuf, and P. Nony, Characterization of Adenovirus-Induced Inverted Terminal Repeat-Independent Amplification of Integrated Adeno-Associated Virus rep-cap Sequences, Journal of Virology, vol.75, issue.1, pp.375-383, 2001.
DOI : 10.1128/JVI.75.1.375-383.2001

L. H. Vandenberghe, R. Xiao, and M. Lock, Efficient Serotype-Dependent Release of Functional Vector into the Culture Medium During Adeno-Associated Virus Manufacturing, Human Gene Therapy, vol.21, issue.10, pp.1251-1257, 2010.
DOI : 10.1089/hum.2010.107

V. Vliet, K. Blouin, V. Agbandje-mckenna, and M. , Proteolytic Mapping of the Adeno-associated Virus Capsid, Molecular Therapy, vol.14, issue.6, pp.809-821, 2006.
DOI : 10.1016/j.ymthe.2006.08.1222

W. Weiss, F. Weiland, and A. Gorg, Protein Detection and Quantitation Technologies for Gel-Based Proteome Analysis, Methods Mol. Biol, vol.564, pp.59-82, 2009.
DOI : 10.1007/978-1-60761-157-8_4

, Address correspondence to: Dr

, Nantes, vol.8

. France,

E. , , pp.32610-0266

, E-mail: rsnyder@cerhb.ufl.edu Received for publication, 2014.